12-month mortality and loss-to-program in antiretroviral-treated children: The IeDEA pediatric West African Database to evaluate AIDS (pWADA), 2000-2008

Ekouevi, Didier K.; Azondekon, Alain; Dicko, Fatoumata; Malateste, Karen; Touré, Pety; Eboua, François T.; Kouadio, Kouakou; Renner, Lorna; Peterson, Kevin; Dabis, François; Signaté Sy, Haby; Leroy, Valeriane
January 2011
BMC Public Health;2011, Vol. 11 Issue 1, p519
Academic Journal
Background: The IeDEA West Africa Pediatric Working Group (pWADA) was established in January 2007 to study the care and treatment of HIV-infected children in this region. We describe here the characteristics at antiretroviral treatment (ART) initiation and study the 12-month mortality and loss-to-program of HIV-infected children followed in ART programs in West Africa. Methods: Standardized data from HIV-infected children followed-up in ART programs were included. Nine clinical centers from six countries contributed to the dataset (Benin, Côte d'Ivoire, Gambia, Ghana, Mali and Senegal). Inclusion criteria were the followings: age 0-15 years and initiated triple antiretroviral drug regimens. Baseline time was the date of ART initiation. WHO criteria was used to define severe immunosuppression based on CD4 count by age or CD4 percent < 15%. We estimated the 12-month Kaplan-Meier probabilities of mortality and loss-toprogram (death or loss to follow-up > 6 months) after ART initiation and factors associated with these two outcomes. Results: Between June 2000 and December 2007, 2170 children were included. Characteristics at ART initiation were the following: median age of 5 years (Interquartile range (IQR: 2-9) and median CD4 percentage of 13% (IQR: 7-19). The most frequent drug regimen consisted of two nucleoside reverse transcriptase inhibitors and one nonnucleoside reverse transcriptase inhibitors (62%). During the first 12 months, 169 (7.8%) children died and 461 (21.2%) were lost-to-program. Overall, in HIV-infected children on ART, the 12-month probability of death was 8.3% (95% Confidence Interval (CI): 7.2-9.6%), and of loss-to-program was 23.1% (95% CI: 21.3-25.0%). Both mortality and loss-to program were associated with advanced clinical stage, CD4 percentage < 15% at ART initiation and year (> 2005) of ART initiation. Conclusion: Innovative and sustainable approaches are needed to better document causes of death and increase retention in HIV pediatric clinics in West Africa.


Related Articles

  • Dominican Children with HIV not Receiving Antiretrovirals: Massage Therapy Influences their Behavior and Development. Hernandez-Reif, Maria; Shor-Posner, Gail; Baez, Jeannette; Soto, Solange; Mendoza, Rosangela; Castillo, Raquel; Quintero, Noaris; Perez, Eddy; Guoyan Zhang // Evidence-based Complementary & Alternative Medicine (eCAM);Sep2008, Vol. 5 Issue 3, p345 

    Forty-eight children (M age=4.8 years) infected with HIV/AIDS and living in the Dominican Republic were randomly assigned to a massage therapy or a play session control group. The children in the massage therapy group received two weekly 20-min massages for 12 weeks; the children in the control...

  • Long-Term Decay of the HIV-1 Reservoir in HIV-1 -- Infected Children Treated with Highly Active Antiretroviral Therapy. Zanchetta, Marisa; Walker, Sarah; Burighel, Nicoletta; Bellanova, Domenico; Rampon, Osvalda; Giaquinto, Carlo; De Rossi, Anita // Journal of Infectious Diseases;6/15/2006, Vol. 193 Issue 12, p1718 

    To investigate the decay of the human immunodeficiency virus type 1 (HIV-1) reservoir in children receiving highly active antiretroviral therapy (HAART), we measured HIV-1 DNA in peripheral blood mononuclear cells from 14 children who achieved and maintained suppression of plasma viremia up to...

  • Main infections in the children under 5 years old in developing countries: reports and perspectives. Courpotin, Christian // Retrovirology;2008 Supplement 1, Vol. 5, Special section p1 

    Spectacular progress in reducing under 5 mortality achieved in the last few decades is projected to continue. There were about 11 million such deaths in 1997 compared to 21 million in 1955. The under-5 mortality rates per 1000 live births was 210 in 1955 and is projected to be 37 in 2025. Today...

  • Pediatric HIV infection guidelines are revised.  // AIDS Alert;Oct2008, Vol. 23 Issue 10, p114 

    The article cites the revisions in the "Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection."

  • Underdosing of antiretrovirals in UK and Irish children with HIV as an example of problems in prescribing medicines to children, 1997-2005: cohort study. Menson, Esse N.; Walker, A. Sarah; Sharland, Mike; Wells, Carole; Tudor-Williams, Gareth; Riordan, F. Andrew I.; Lyall, E. G. Hermione; Gibb, Diana M. // BMJ: British Medical Journal (International Edition);5/20/2006, Vol. 332 Issue 7551, p1183 

    Objective To measure the extent of underdosing of antiretroviral drugs in children. Design Multicentre cohort study. Setting Clinical centres in hospitals in the United Kingdom and Ireland in the collaborative HIV paediatric study (CHIPS). Participants 615 HIV infected children aged 2-12 years...

  • Essential medicines for children. Hoppu, Kalle; Ranganathan, Shalini Sri // Archives of Disease in Childhood;Feb2015, Vol. 100 Issue Supp1, ps38 

    Millions of children die every year before they reach the age of 5 years, of conditions largely treatable with existing medicines. The WHO Model List of Essential Medicines was launched in 1977 to make the most necessary drugs available to populations whose basic health needs could not be met by...

  • The burden of pediatric HIV/AIDS in Constanta, Romania: a cross-sectional study. Kozinetz, Claudia A.; Matusa, Rodica; Cazacu, Andreaa; Kozinetz, C A; Matusa, R; Cazacu, A // BMC Infectious Diseases;2001, Vol. 1 Issue 1, p7 

    Background: By 1990, 94 percent of the acquired immunodeficiency syndrome (AIDS) cases in Romania were in children less than 13 years of age. The majority of the cases were identified in the city of Constanta. The purpose of this paper was to describe the current burden of pediatric...

  • Pediatric HIV Clinical Care Resources and Management Practices in Asia: A Regional Survey of the TREAT Asia Pediatric Network. Prasitsuebsai, Wasana; Bowen, Asha C.; Pang, Joselyn; Hesp, Cees; Kariminia, Azar; Sohn, Annette H. // AIDS Patient Care & STDs;Feb2010, Vol. 24 Issue 2, p127 

    Characterizing intraregional differences in current pediatric HIV care and treatment in Asia can guide the development of clinical practice guidelines and improve the understanding of local resource availability. The Therapeutics Research, Education, and AIDS Training in Asia (TREAT Asia)...

  • Despite access to ART, mortality still reported among children in Uganda.  // Infectious Diseases in Children;Aug2012, Vol. 25 Issue 8, p12 

    The article reports on the 19th International AIDS Conference where a study presented by Ruth Atukunda of the University of Maryland School of Medicine Institute of Human Virology-Uganda Program and colleagues advocated for careful documentation of CD4 counts and early initiation of...


Other Topics